Table 3.
Event rate of all-cause and breast cancer–specific mortality among women exposed to glucose-lowering therapies with HRs from secondary analyses modeling glucose-lowering drugs as a time-varying never/ever exposure
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.